These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30124729)

  • 1. A Phase 2, Controlled, Dose-Ranging Study of SB208, an Investigational Topical Nitric Oxide-Releasing Drug, for the Treatment of Tinea Pedis.
    Elewski BE; Kircik LH; Stasko N; De Leon E; Enloe C; Durham T; Maeda-Chubachi T
    J Drugs Dermatol; 2018 Aug; 17(8):888-893. PubMed ID: 30124729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of naftifine HCl Gel 2% in the treatment of interdigital and moccasin type tinea pedis: pooled results from two multicenter, randomized, double-blind, vehicle-controlled trials.
    Stein Gold LF; Parish LC; Vlahovic T; Plaum S; Kircik L; Fleischer AB; Verma A; Olayinka B; Hardas B
    J Drugs Dermatol; 2013 Aug; 12(8):911-8. PubMed ID: 23986165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Econazole nitrate foam 1% for the treatment of tinea pedis: results from two double-blind, vehicle-controlled, phase 3 clinical trials.
    Elewski BE; Vlahovic TC
    J Drugs Dermatol; 2014 Jul; 13(7):803-8. PubMed ID: 25007362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naftifine Hydrochloride Gel 2%: An Effective Topical Treatment for Moccasin-Type Tinea Pedis.
    Stein Gold LF; Vlahovic T; Verma A; Olayinka B; Fleischer AB
    J Drugs Dermatol; 2015 Oct; 14(10):1138-44. PubMed ID: 26461826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ciclopirox gel in the treatment of patients with interdigital tinea pedis.
    Aly R; Fisher G; Katz I; Levine N; Lookingbill DP; Lowe N; Menter A; Morman M; Pariser DM; Roth HL; Savin RC; Shavin JS; Stewart D; Taylor JR; Tucker S; Wortzman M
    Int J Dermatol; 2003 Sep; 42 Suppl 1():29-35. PubMed ID: 14567368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study.
    Ortonne JP; Korting HC; Viguié-Vallanet C; Larnier C; Savaluny E
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1307-13. PubMed ID: 17062050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efinaconazole Topical Solution, 10% Efficacy in Patients with Onychomycosis and Coexisting Tinea Pedis.
    Markinson B; Caldwell B
    J Am Podiatr Med Assoc; 2015 Sep; 105(5):407-11. PubMed ID: 26429609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, vehicle-controlled efficacy and safety study of naftifine 2% cream in the treatment of tinea pedis.
    Parish LC; Parish JL; Routh HB; Fleischer AB; Avakian EV; Plaum S; Hardas B
    J Drugs Dermatol; 2011 Nov; 10(11):1282-8. PubMed ID: 22052309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of once-daily luliconazole 1% cream in patients ≥12 years of age with interdigital tinea pedis: a phase 3, randomized, double-blind,vehicle-controlled study.
    Jarratt M; Jones T; Adelglass J; Bucko A; Pollak R; Roman-Miranda A; Olin JT; Swinyer L
    J Drugs Dermatol; 2014 Jul; 13(7):838-46. PubMed ID: 25007368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-week therapy with twice-daily butenafine 1% cream versus vehicle in the treatment of tinea pedis: a multicenter, double-blind trial.
    Savin R; De Villez RL; Elewski B; Hong S; Jones T; Lowe N; Lucky A; Reyes B; Stewart D; Willis I
    J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):S15-9. PubMed ID: 9039200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparable efficacy and safety of various topical formulations of terbinafine in tinea pedis irrespective of the treatment regimen: results of a meta-analysis.
    Korting HC; Kiencke P; Nelles S; Rychlik R
    Am J Clin Dermatol; 2007; 8(6):357-64. PubMed ID: 18039018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-finding comparative study of 2 weeks of luliconazole cream treatment for tinea pedis--comparison between three groups (1%, 0.5%, 0.1%) by a multi-center randomised double-blind study.
    Watanabe S; Takahashi H; Nishikawa T; Takiuchi I; Higashi N; Nishimoto K; Kagawa S; Yamaguchi H; Ogawa H
    Mycoses; 2007 Jan; 50(1):35-40. PubMed ID: 17302746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of terbinafine 1% topical solution used for 1 week compared with 4 weeks clotrimazole 1% topical solution in the treatment of interdigital tinea pedis: a randomized, double-blind, multi-centre, 8-week clinical trial.
    Schopf R; Hettler O; Bräutigam M; Weidinger G; Kaben U; Mayser P; Resl V
    Mycoses; 1999; 42(5-6):415-20. PubMed ID: 10536434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy, tolerability and consumer acceptability of terbinafine topical spray versus terbinafine topical solution: a phase IIa, randomised, observer-blind, comparative study.
    Brown M; Evans C; Muddle A; Turner R; Lim S; Reed J; Traynor M
    Am J Clin Dermatol; 2013 Oct; 14(5):413-9. PubMed ID: 23740211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the efficacy of ciclopirox 0.77% gel in the treatment of tinea pedis interdigitalis (dermatophytosis complex) in a randomized, double-blind, placebo-controlled trial.
    Gupta AK; Skinner AR; Cooper EA
    Int J Dermatol; 2005 Jul; 44(7):590-3. PubMed ID: 15985032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical comparison of the efficacy and tolerability of once daily Canesten with twice daily Nizoral (clotrimazole 1% cream vs. ketoconazole 2% cream) during a 28-day topical treatment of interdigital tinea pedis.
    Suschka S; Fladung B; Merk HF
    Mycoses; 2002 Apr; 45(3-4):91-6. PubMed ID: 12000508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of 1 % terbinafine film-forming solution in Chinese patients with tinea pedis: a randomized, double-blind, placebo-controlled, multicenter, parallel-group study.
    Li RY; Wang AP; Xu JH; Xi LY; Fu MH; Zhu M; Xu ML; Li XQ; Lai W; Liu WD; Lu XY; Gong ZQ
    Clin Drug Investig; 2014 Mar; 34(3):223-30. PubMed ID: 24477462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of terbinafine 1% solution in the treatment of interdigital tinea pedis and tinea corporis or tinea cruris.
    Lebwohl M; Elewski B; Eisen D; Savin RC
    Cutis; 2001 Mar; 67(3):261-6. PubMed ID: 11270304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-duration topical treatment of tinea pedis using terbinafine emulsion gel: results of a dose-ranging clinical trial.
    James IG; Loria-Kanza Y; Jones TC
    J Dermatolog Treat; 2007; 18(3):163-8. PubMed ID: 17538805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, randomized, vehicle-controlled study evaluating the efficacy and safety of naftifine 2% cream in tinea cruris.
    Parish LC; Parish JL; Routh HB; Avakian E; Olayinka B; Pappert EJ; Plaum S; Fleischer AB; Hardas B
    J Drugs Dermatol; 2011 Oct; 10(10):1142-7. PubMed ID: 21968664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.